Cargando…
Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder
Omics technologies emerged as complementary strategies to genomics in the attempt to understand human illnesses. In general, proteomics technologies emerged earlier than those of metabolomics for major depressive disorder (MDD) research, but both are driven by the identification of proteins and/or m...
Autor principal: | Martins-de-Souza, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984892/ https://www.ncbi.nlm.nih.gov/pubmed/24733971 |
Ejemplares similares
-
Neuroimaging-based biomarkers for treatment selection in major depressive disorder
por: Dunlop, Boadie W., et al.
Publicado: (2014) -
Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications
por: Dwivedi, Yogesh
Publicado: (2014) -
Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics
por: Gui, Si-Wen, et al.
Publicado: (2018) -
Proteomic characterization of HIV-1 Tat interactome
por: Gautier, VW, et al.
Publicado: (2006) -
Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other brain-related disorders
por: Sibille, Etienne
Publicado: (2013)